91 related articles for article (PubMed ID: 22326647)
1. A rapidly growing number of therapeutics targeting tumor cell-intrinsic and -extrinsic processes is under development for individualized treatment of cancer patients.
Giske CG; Jonkers J
Drug Resist Updat; 2012; 15(1-2):1. PubMed ID: 22326647
[No Abstract] [Full Text] [Related]
2. The search for optimal response prediction in cancer leads to a personalized approach.
Van Cutsem E; Ciardiello F
Target Oncol; 2010 Mar; 5(1):3-4. PubMed ID: 20349283
[No Abstract] [Full Text] [Related]
3. Targeted therapy: overcoming drug resistance with clinical cancer genome.
Ziogas DE; Katsios CS; Tzaphlidou M; Roukos DH
Expert Rev Anticancer Ther; 2012 Jul; 12(7):861-4. PubMed ID: 22845399
[No Abstract] [Full Text] [Related]
4. Genetic determinants of anticancer drug activity: towards a global approach to personalized cancer medicine.
Picker A; Jackson DB
Expert Rev Mol Diagn; 2011 Jul; 11(6):567-77. PubMed ID: 21745011
[TBL] [Abstract][Full Text] [Related]
5. Preface: National Cancer Act.
Smalley KS
Adv Pharmacol; 2012; 65():xi-xiii. PubMed ID: 22959037
[No Abstract] [Full Text] [Related]
6. Functional drug-gene interactions in lung cancer.
Smida M; Nijman SM
Expert Rev Mol Diagn; 2012 Apr; 12(3):291-302. PubMed ID: 22468819
[TBL] [Abstract][Full Text] [Related]
7. The end of chemotherapy in renal cell carcinoma: for much but not for all.
Iacovelli R; Raimondi C; Palazzo A
Am J Clin Oncol; 2010 Oct; 33(5):522-3. PubMed ID: 20924226
[No Abstract] [Full Text] [Related]
8. Cancer cell line encyclopedia will help researchers match drugs to patients in clinical trials.
McBride D
ONS Connect; 2012 Jun; 27(6):21. PubMed ID: 22774345
[No Abstract] [Full Text] [Related]
9. Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy.
Bianco R; Troiani T; Tortora G; Ciardiello F
Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S159-71. PubMed ID: 16113092
[TBL] [Abstract][Full Text] [Related]
10. [Personalized treatment of cancer: utopia or chance?].
Thiel E
Dtsch Med Wochenschr; 2010 Sep; 135(38):1851. PubMed ID: 20842603
[No Abstract] [Full Text] [Related]
11. Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics.
Lee AJ; Swanton C
Biochem Pharmacol; 2012 Apr; 83(8):1013-20. PubMed ID: 22192819
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapies: the answer to individualized treatment?
Hutchinson L
Nat Clin Pract Oncol; 2007 Jun; 4(6):323. PubMed ID: 17534387
[No Abstract] [Full Text] [Related]
13. [Individualized cancer therapy and treatment based on syndrome differentiation].
Wang ZY
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):158-60. PubMed ID: 23714675
[No Abstract] [Full Text] [Related]
14. Modulation of cell sensitivity to antitumor agents by targeting survival pathways.
Perego P; Cossa G; Zuco V; Zunino F
Biochem Pharmacol; 2010 Nov; 80(10):1459-65. PubMed ID: 20688050
[TBL] [Abstract][Full Text] [Related]
15. A missing link in genotype-directed cancer therapy.
Bernards R
Cell; 2012 Oct; 151(3):465-8. PubMed ID: 23101617
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance in cancer - searching for mechanisms, markers and therapeutic agents.
O'Connor R; Clynes M; Dowling P; O'Donovan N; O'Driscoll L
Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):805-17. PubMed ID: 18028026
[TBL] [Abstract][Full Text] [Related]
17. Markers involved in resistance to cytotoxics and targeted therapeutics in pancreatic cancer.
El Maalouf G; Le Tourneau C; Batty GN; Faivre S; Raymond E
Cancer Treat Rev; 2009 Apr; 35(2):167-74. PubMed ID: 19027240
[TBL] [Abstract][Full Text] [Related]
18. [Current status and problems of tailor-made medicine in anticancer therapy].
Miya T
Gan To Kagaku Ryoho; 2007 Apr; 34(4):515-9. PubMed ID: 17431334
[TBL] [Abstract][Full Text] [Related]
19. Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1.
Gillet JP; Gottesman MM
Drug Resist Updat; 2012; 15(1-2):2-4. PubMed ID: 22465109
[No Abstract] [Full Text] [Related]
20. Molecular markers of multiple drug resistance in breast cancer.
O'Driscoll L; Clynes M
Chemotherapy; 2006; 52(3):125-9. PubMed ID: 16612055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
